Case number 1:23-cv-00877
Vifor Fresenius Medical Care Renal Pharma Ltd. et al v. Aurobindo Pharma Ltd. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jan 3, 2024 | 26 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s). (Attachments: # 1 Stipulation of Dismissal)(mdb) (Entered: 01/03/2024) (0) |
| Jan 3, 2024 | 25 | SO ORDERED re 24 Stipulation and Order of Dismissal ***Civil Case Terminated. Signed by Judge Maryellen Noreika on 1/3/2024. (dlw) (Entered: 01/03/2024) (2) |
| Dec 28, 2023 | 24 | STIPULATION of Dismissal by Vifor Fresenius Medical Care Renal Pharma France S.A.S., Vifor Fresenius Medical Care Renal Pharma Ltd.. (Farnan, Brian) (Entered: 12/28/2023) (2) |
| Dec 7, 2023 | N/A | Pro Hac Vice Attorney George J. Barry, III for Aurobindo Pharma Ltd. and Aurobindo Pharma USA, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (apk) (Entered: 12/07/2023) (0) |
| Dec 6, 2023 | N/A | SO ORDERED re 23 MOTION for Pro Hac Vice Appearance of Attorney George J. Barry III filed by Aurobindo Pharma USA, Inc., Aurobindo Pharma Ltd. ORDERED by Judge Maryellen Noreika on 12/6/2023. (dlw) (Entered: 12/06/2023) (0) |
| Dec 6, 2023 | 23 | MOTION for Pro Hac Vice Appearance of Attorney George J. Barry III - filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc.. (Myer, R.) (Entered: 12/06/2023) (2) |
| Nov 15, 2023 | 22 | NOTICE OF SERVICE of Defendants Aurobindo Pharma Limited and Aurobindo Pharma USA, Inc.'s Disclosures Pursuant to Paragraph 3 of the Delaware Default Standard for Discovery filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc..(Myer, R.) (Entered: 11/15/2023) (3) |
| Nov 15, 2023 | 21 | NOTICE OF SERVICE of Plaintiffs' Paragraph 4(a) Disclosures filed by Vifor Fresenius Medical Care Renal Pharma France S.A.S., Vifor Fresenius Medical Care Renal Pharma Ltd..(Farnan, Brian) (Entered: 11/15/2023) (2) |
| Nov 3, 2023 | 20 | STIPULATED PROTECTIVE ORDER. Signed by Judge Maryellen Noreika on 11/3/2023. (dlw) (Entered: 11/03/2023) (21) |
| Nov 2, 2023 | 19 | PROPOSED ORDER // Protective Order by Vifor Fresenius Medical Care Renal Pharma France S.A.S., Vifor Fresenius Medical Care Renal Pharma Ltd. (Farnan, Michael) Modified on 11/3/2023 (dlw). (Entered: 11/02/2023) (21) |
| Oct 26, 2023 | N/A | SO ORDERED re 18 STIPULATION TO EXTEND TIME to submit a proposed Protective Order to 11/2/2023. ORDERED by Judge Maryellen Noreika on 10/26/2023. (dlw) (Entered: 10/26/2023) (0) |
| Oct 26, 2023 | 18 | STIPULATION TO EXTEND TIME to submit a proposed Protective Order to 11/2/2023 - filed by Vifor Fresenius Medical Care Renal Pharma France S.A.S., Vifor Fresenius Medical Care Renal Pharma Ltd.. (Farnan, Brian) (Entered: 10/26/2023) (1) |
| Oct 23, 2023 | 17 | NOTICE OF SERVICE of Defendants Aurobindo Pharma Ltd. and Aurobindo Pharma USA, Inc.'s Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a)(1) filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc..(Myer, R.) (Entered: 10/23/2023) (2) |
| Oct 23, 2023 | 16 | NOTICE OF SERVICE of Plaintiffs' Initial Disclosures filed by Vifor Fresenius Medical Care Renal Pharma France S.A.S., Vifor Fresenius Medical Care Renal Pharma Ltd..(Farnan, Brian) (Entered: 10/23/2023) (2) |
| Oct 16, 2023 | 15 | SCHEDULING ORDER: Joinder of Parties due by 6/21/2024. Amended Pleadings due by 6/21/2024. Fact Discovery completed by 7/12/2024. Opening Expert Reports due by 11/22/2024. Rebuttal Expert Reports due by 12/20/2024. Reply Expert Reports due by 1/10/2025. Expert Discovery due by 2/21/2025. Claim Construction Opening Brief served by 8/2/2024. Claim Construction Answering Brief served by 8/30/2024. Claim Construction Reply Brief served by 9/20/2024. Claim Construction Surreply Brief served by 10/4/2024. Joint Claim Construction Brief filed by 10/11/2024. A Markman Hearing is set for 11/1/2024 at 10:00 AM in Courtroom 4A before Judge Maryellen Noreika. A Pretrial Conference is set for 5/27/2025 at 04:30 PM in Courtroom 4A before Judge Maryellen Noreika. A 5-day Bench Trial is set for 6/2/2025 at 09:00 AM in Courtroom 4A before Judge Maryellen Noreika. Signed by Judge Maryellen Noreika on 10/16/2023. (dlw) (Entered: 10/16/2023) (11) |
| Oct 10, 2023 | 14 | PROPOSED ORDER // Scheduling Order by Vifor Fresenius Medical Care Renal Pharma France S.A.S., Vifor Fresenius Medical Care Renal Pharma Ltd. (Attachments: # 1 Letter to The Honorable Maryellen Noreika)(Farnan, Michael) Modified on 10/10/2023 (dlw). (Entered: 10/10/2023) (0) |
| Sep 15, 2023 | N/A | Pro Hac Vice Attorneys Steven C. Cherny and Matthew A. Traupman for Vifor Fresenius Medical Care Renal Pharma France S.A.S. and Vifor Fresenius Medical Care Renal Pharma Ltd. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) (Entered: 09/15/2023) (0) |
| Sep 14, 2023 | N/A | Pro Hac Vice Attorney Geoffrey A. Kirsner for Vifor Fresenius Medical Care Renal Pharma France S.A.S., Vifor Fresenius Medical Care Renal Pharma Ltd. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (twk) (Entered: 09/14/2023) (0) |
| Sep 12, 2023 | 13 | NOTICE OF SERVICE of Production of Defendants' Core Technical Documents Pursuant to Paragraph 4(b) of the Delaware Default Standard for Discovery and Pursuant to the Standing Order Regarding Hatch-Waxman Cases in Which Infringement is Alleged filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc..(Myer, R.) (Entered: 09/12/2023) (3) |
| Sep 12, 2023 | N/A | SO ORDERED re 12 MOTION for Pro Hac Vice Appearance of Attorney Steven C. Cherny, Matthew A. Traupman, and Geoffrey A. Kirsner filed by Vifor Fresenius Medical Care Renal Pharma Ltd., Vifor Fresenius Medical Care Renal Pharma France S.A.S. ORDERED by Judge Maryellen Noreika on 9/12/2023. (dlw) (Entered: 09/12/2023) (0) |
| Sep 12, 2023 | 12 | MOTION for Pro Hac Vice Appearance of Attorney Steven C. Cherny, Matthew A. Traupman, and Geoffrey A. Kirsner - filed by Vifor Fresenius Medical Care Renal Pharma France S.A.S., Vifor Fresenius Medical Care Renal Pharma Ltd.. (Farnan, Brian) (Entered: 09/12/2023) (4) |
| Sep 8, 2023 | N/A | Pro Hac Vice Attorneys Timothy H. Kratz and Michael P. Hogan for Aurobindo Pharma Ltd. and Aurobindo Pharma USA, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) (Entered: 09/08/2023) (0) |
| Sep 8, 2023 | N/A | SO ORDERED, re 11 MOTION for Pro Hac Vice Appearance of Attorney Timothy H. Kratz and Michael P. Hogan filed by Aurobindo Pharma USA, Inc., Aurobindo Pharma Ltd.. ORDERED by Judge Maryellen Noreika on 9/8/2023. (mdb) (Entered: 09/08/2023) (0) |
| Sep 8, 2023 | 11 | MOTION for Pro Hac Vice Appearance of Attorney Timothy H. Kratz and Michael P. Hogan - filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc.. (Myer, R.) (Entered: 09/08/2023) (3) |
| Sep 7, 2023 | 10 | ORAL ORDER - IT IS HEREBY ORDERED that, within thirty (30) days from the date of this Order, the parties shall confer regarding proposed dates in the scheduling order and shall submit a proposed order, which is also consistent with the following guidance. A Bench trial will begin on 6/2/2025. The parties shall provide final contentions (i.e., final infringement and invalidity contentions, as well as final non-infringement and validity contentions) around the time that fact discovery closes (i.e., several weeks prior to or after the deadline to complete fact discovery) and at least three weeks before Plaintiffs serves their opening claim construction brief. Final contentions shall include a party's contentions under its proposed construction(s), as well as under the opposing construction(s) (if such an alternative contention exists). As such, the parties are encouraged to exchange proposed claim terms and proposed constructions early in the case but in no event later than necessary to allow the parties to include alternative contentions in their final contentions. The joint claim construction chart shall be due one week after the parties have completed their exchange of final contentions, and the joint claim construction brief must be filed at least three weeks before the claim construction hearing. The parties shall leave at least three weeks between the claim construction hearing and the opening of expert discovery. The parties are to use the Court's form scheduling order, which is posted at http://www.ded.uscourts.gov (see Chambers, Judge Noreika, Forms), and the parties must include a proposal for the length and timing of trial. If there are disputes or issues that the Court needs to address in the proposed scheduling order, the parties shall direct the Court to the paragraph numbers in which those appear in a cover letter to the Court. ORDERED by Judge Maryellen Noreika on 9/7/2023. (dlw) (Entered: 09/07/2023) (0) |
| Sep 1, 2023 | 9 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Aurobindo Pharma Limited for Aurobindo Pharma USA, Inc. filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc.. (Myer, R.) (Entered: 09/01/2023) (2) |
| Sep 1, 2023 | 8 | ANSWER to 1 Complaint, by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc..(Myer, R.) (Entered: 09/01/2023) (29) |
| Aug 21, 2023 | 7 | SUMMONS Returned Executed by Vifor Fresenius Medical Care Renal Pharma Ltd., Vifor Fresenius Medical Care Renal Pharma France S.A.S..Aurobindo Pharma USA, Inc. served on 8/11/2023, answer due 9/1/2023. (Farnan, Brian) (Entered: 08/21/2023) (2) |
| Aug 16, 2023 | N/A | Case Assigned to Judge Maryellen Noreika. Please include the initials of the Judge (MN) after the case number on all documents filed. (rjb) (Entered: 08/16/2023) (0) |
| Aug 10, 2023 | 6 | Summons Issued as to Aurobindo Pharma USA, Inc. on 8/10/2023. (jfm) (Entered: 08/10/2023) (2) |
| Aug 10, 2023 | 5 | Disclosure Statement pursuant to Rule 7.1: identifying Other Affiliate CSL Limited, Other Affiliate Vifor Pharma AG, Other Affiliate Fresenius Medical Care AG & Co. KGaA, Other Affiliate Vifor Pharma Participations AG, Other Affiliate CSL Vifor Group, Other Affiliate CSL Behring AG, Other Affiliate CSL Behring Holdings Limited, Other Affiliate Behrin (Holdings) Pty Ltd. for Vifor Fresenius Medical Care Renal Pharma France S.A.S., Vifor Fresenius Medical Care Renal Pharma Ltd. filed by Vifor Fresenius Medical Care Renal Pharma France S.A.S., Vifor Fresenius Medical Care Renal Pharma Ltd. (jfm) (Entered: 08/10/2023) (2) |
| Aug 10, 2023 | 4 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) see attached. (jfm) (Entered: 08/10/2023) (2) |
| Aug 10, 2023 | 3 | Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: Vifor Fresenius Medical Care Renal Pharma Ltd. on July 4, 2023, and Vifor Fresenius Medical Care Renal Pharma France S.A.S. on June 28, 2023. Date of Expiration of Patent: See Attached.Thirty Month Stay Deadline: 1/4/2026. (jfm) (Entered: 08/10/2023) (3) |
| Aug 10, 2023 | 2 | Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (jfm) (Entered: 08/10/2023) (3) |
| Aug 10, 2023 | 1 | Complaint* (1) |
